Ulcerative Colitis Clinical Trials in Phoenix

Showing 561-580 of 587 trials

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

NCT00515164

The purpose of this study it to evaluate the efficacy and safety of the 20 mL BLVR System in patients with advanced upper lobe predominant emphysema.

Pulmonary EmphysemaChronic Obstructive Pulmonary Disease

Aeris Therapeutics22 participantsStarted Aug 2007

Phoenix, Arizona, United States • Iowa City, Iowa, United States • Topeka, Kansas, United States +5 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

NCT00877383

This study assessed the efficacy and safety of indacaterol (150 µg once daily \[od\]) when combined with tiotropium (18 µg od) versus tiotropium (18 µg od) treatment alone in patients with chronic obstructive pulmonary disease (COPD).

Chronic Obstructive Pulmonary Disease (COPD)

Novartis Pharmaceuticals1,142 participantsStarted Apr 2009

Anniston, Alabama, United States • Birmingham, Alabama, United States • Jasper, Alabama, United States +173 more locations

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

Ulcerative Colitis Trials in Other Cities

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD

Prevention of School Dropout for Mexican American Adolescents

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

12-week Efficacy of Indacaterol

Efficacy of SNX-1012 in the Treatment of Oral Mucositis

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Clinical Study to Evaluate the Safety and Efficacy of the Vela100

Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Quality of Life in Pediatric Inflammatory Bowel Disease

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control

Other Conditions in Phoenix